ESC Premium Access

Outcomes in vitamin K antagonist treated atrial fibrillation patients with stable international normalized ratios

Congress Session

About the speaker

Doctor Anders Nissen Bonde

Gentofte University Hospital, Gentofte (Denmark)
0 follower

6 more presentations in this session

Adherence to anticoagulant drugs in patients with atrial fibrillation and stroke in real clinical practice

Speaker: Professor D. Duplyakov (Samara, RU)


Periprocedural anticoagulation is associated with the risk of thromboembolism after elective cardioversion of atrial fibrillation.

Speaker: Doctor T. Hellman (Turku, FI)


Reduced fibrin clot permeability is associated with an increased risk of both ischemic stroke and major bleeding in atrial fibrillation patients treated with vitamin k antagonists

Speaker: Professor A. Undas (Krakow, PL)


The impact of age on the effectiveness and safety of the NOACs versus warfarin for stroke prevention in atrial fibrillation

Speaker: Doctor P. Noseworthy (Rochester, US)


Use of novel oral anticoagulants in patients with atrial fibrillation and moderate to severe renal dysfunction: findings from a prospective national registry

Speaker: Professor I. Goldenberg (Rochester, US)


Access the full session

Progress in stroke prevention in atrial fibrillation

Speakers: Doctor A. Nissen Bonde, Professor D. Duplyakov, Doctor T. Hellman, Professor A. Undas, Doctor P. Noseworthy...

About the event



26 August - 30 August 2017

Sessions Presentations

This platform is supported by

logo Novo Nordisk